Impact of age on mid- to long-term outcomes of transvaginal native tissue repair for apical vaginal prolapse

Neurourology and Urodynamics
Lindsay M KissaneHolly E Richter

Abstract

To compare surgical success rates in older versus younger women a minimum of 3 years post transvaginal native tissue repair for apical prolapse. Post-operative symptom severity and quality of life improvement, surgical complications and retreatment were also examined. Women who underwent transvaginal native tissue repair for apical prolapse between 2011 and 2013 were eligible. Subjects completed the pelvic floor distress inventory (PFDI-20), pelvic floor impact questionnaire (PFIQ-7), and patient global impression of improvement (PGI-I), and were categorized as "younger" (age <70) or "older" (age ≥70). The primary outcome of surgical success was defined as the absence of bulge symptoms and no re-treatment for prolapse. Of 641 eligible patients, response rate was 51.0%. 62.7% of subjects had hysterectomy prior to index surgery. Surgical success was noted in 72.9% of younger and 82.2% of older subjects (Adjusted odds ratio [aOR] 1.72, 95% CI [0.93, 3.17]). Older women had greater improvement from baseline in PFDI-20 score (-87.5 [IQR 74.0] vs -54.2 [IQR 80.2], P = 0.01). Retreatment rate and surgical complication rates were similar between groups (both P > 0.05). Older and younger women had similar surgical success rates a minimu...Continue Reading

References

Jul 1, 1996·American Journal of Obstetrics and Gynecology·R C BumpA R Smith
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Kathie L HullfishWilliam D Steers
May 20, 2003·Acta Obstetricia Et Gynecologica Scandinavica·Kari NieminenPentti K Heinonen
Jan 8, 2004·American Journal of Obstetrics and Gynecology·Marc R Toglia, Thomas E Nolan
Nov 18, 2004·American Journal of Obstetrics and Gynecology·James L WhitesideMark D Walters
Feb 18, 2005·Acta Obstetricia Et Gynecologica Scandinavica·Karlijn J SchweitzerAlfredo L Milani
May 6, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Jasmine S TanUNKNOWN San Diego Pelvic Floor Consortium
May 20, 2005·American Journal of Obstetrics and Gynecology·Kevin J SteppMark D Walters
May 2, 2006·American Journal of Obstetrics and Gynecology·Vivian W SungDeborah L Myers
Aug 8, 2006·American Journal of Obstetrics and Gynecology·Wayne H FriedmanWilliam J Hoskins
Nov 18, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Matthew D BarberMark D Walters
Mar 3, 2007·International Urogynecology Journal and Pelvic Floor Dysfunction·I Diez-ItzaA Becerro
Jun 1, 2007·Journal of the American Geriatrics Society·Holly E RichterUNKNOWN Pelvic Floor Disorders Network
Sep 19, 2008·JAMA : the Journal of the American Medical Association·Ingrid NygaardUNKNOWN Pelvic Floor Disorders Network
Jan 10, 2009·Contemporary Clinical Trials·Matthew D BarberUNKNOWN Pelvic Floor Disorders Network
Aug 25, 2009·Obstetrics and Gynecology·Matthew D BarberUNKNOWN Pelvic Floor Disorders Network
Sep 5, 2009·American Journal of Obstetrics and Gynecology·Vivian W SungDeborah L Myers
Dec 17, 2009·International Urogynecology Journal·Sushma SrikrishnaLinda Cardozo
Mar 12, 2013·The Journal of Urology·Joy A GreerLily A Arya
Sep 17, 2013·American Journal of Obstetrics and Gynecology·Anna C KirbyShawn A Menefee
Jan 28, 2014·Obstetrics and Gynecology·Jennifer M WuAlayne D Markland
Oct 27, 2015·Annals of Internal Medicine·Albert L Siu, UNKNOWN U S Preventive Services Task Force
Jun 16, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceAlbert L Siu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.